These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21559441)

  • 1. Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda.
    Bakanda C; Birungi J; Mwesigwa R; Nachega JB; Chan K; Palmer A; Ford N; Mills EJ
    PLoS One; 2011 Apr; 6(4):e19261. PubMed ID: 21559441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.
    Mills EJ; Bakanda C; Birungi J; Chan K; Ford N; Cooper CL; Nachega JB; Dybul M; Hogg RS
    Ann Intern Med; 2011 Aug; 155(4):209-16. PubMed ID: 21768555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda.
    Kiboneka A; Wangisi J; Nabiryo C; Tembe J; Kusemererwa S; Olupot-Olupot P; Joffres M; Anema A; Cooper CL; Montaner JS; Mills EJ
    AIDS; 2008 Nov; 22(18):2493-9. PubMed ID: 19005272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Treatment Failure in HIV-Positive Children Receiving Combination Antiretroviral Therapy: Cohort Data From Mozambique and Uganda.
    Costenaro P; Penazzato M; Lundin R; Rossi G; Massavon W; Patel D; Nabachwa S; Franceschetto G; Morelli E; Bilardi D; Nannyonga MM; Atzori A; Mastrogiacomo ML; Mazza A; Putoto G; Giaquinto C
    J Pediatric Infect Dis Soc; 2015 Mar; 4(1):39-48. PubMed ID: 26407356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda.
    Abaasa AM; Todd J; Ekoru K; Kalyango JN; Levin J; Odeke E; Karamagi CA
    BMC Health Serv Res; 2008 Nov; 8():241. PubMed ID: 19021908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics, mortality and outcomes at transition for adolescents with perinatal HIV infection in Asia.
    Bartlett AW; Truong KH; Songtaweesin WN; Chokephaibulkit K; Hansudewechakul R; Ly PS; Lumbiganon P; Sudjaritruk T; Nguyen LV; Do VC; Kumarasamy N; Nik Yusoff NK; Kurniati N; Fong MS; Wati DK; Nallusamy R; Sohn AH; Law MG; Mohamed TJ
    AIDS; 2018 Jul; 32(12):1689-1697. PubMed ID: 29794827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
    ; Judd A; Chappell E; Turkova A; Le Coeur S; Noguera-Julian A; Goetghebuer T; Doerholt K; Galli L; Pajkrt D; Marques L; Collins IJ; Gibb DM; González Tome MI; Navarro M; Warszawski J; Königs C; Spoulou V; Prata F; Chiappini E; Naver L; Giaquinto C; Thorne C; Marczynska M; Okhonskaia L; Posfay-Barbe K; Ounchanum P; Techakunakorn P; Kiseleva G; Malyuta R; Volokha A; Ene L; Goodall R
    PLoS Med; 2018 Jan; 15(1):e1002491. PubMed ID: 29381702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm
    Mutembo S; Mutanga JN; Musokotwane K; Alisheke L; Whalen CC
    BMC Infect Dis; 2016 Oct; 16(1):572. PubMed ID: 27751168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.
    Achenbach CJ; Cole SR; Kitahata MM; Casper C; Willig JH; Mugavero MJ; Saag MS
    AIDS; 2011 Mar; 25(5):691-700. PubMed ID: 21160411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male gender predicts mortality in a large cohort of patients receiving antiretroviral therapy in Uganda.
    Mills EJ; Bakanda C; Birungi J; Chan K; Hogg RS; Ford N; Nachega JB; Cooper CL
    J Int AIDS Soc; 2011 Nov; 14():52. PubMed ID: 22050673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil.
    Cardoso SW; Luz PM; Velasque L; Torres TS; Tavares IC; Ribeiro SR; Moreira RI; Veloso VG; Moore RD; Grinsztejn B
    BMC Infect Dis; 2014 Dec; 14():699. PubMed ID: 25523385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality in Children with Human Immunodeficiency Virus Initiating Treatment: A Six-Cohort Study in Latin America.
    Luque MT; Jenkins CA; Shepherd BE; Padgett D; Rouzier V; Succi RCM; Machado DM; McGowan CC; Vermund SH; Pinto JA
    J Pediatr; 2017 Mar; 182():245-252.e1. PubMed ID: 28081884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival outcomes of HIV infected children receiving antiretroviral therapy: an observational study from Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Jan; 19(1):115. PubMed ID: 30691416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Density of healthcare providers and patient outcomes: evidence from a nationally representative multi-site HIV treatment program in Uganda.
    Bakanda C; Birungi J; Mwesigwa R; Zhang W; Hagopian A; Ford N; Mills EJ
    PLoS One; 2011 Jan; 6(1):e16279. PubMed ID: 21264224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy.
    McManus H; O'Connor CC; Boyd M; Broom J; Russell D; Watson K; Roth N; Read PJ; Petoumenos K; Law MG;
    PLoS One; 2012; 7(11):e48839. PubMed ID: 23144991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.
    Bisson GP; Gross R; Bellamy S; Chittams J; Hislop M; Regensberg L; Frank I; Maartens G; Nachega JB
    PLoS Med; 2008 May; 5(5):e109. PubMed ID: 18494555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of adverse outcomes in HIV-1-infected children receiving combination antiretroviral treatment: results from a DREAM cohort in sub-Saharan Africa.
    Marazzi MC; De Luca S; Palombi L; Scarcella P; Ciccacci F; Ceffa S; Nielsen-Saines K; De Luca A; Mancinelli S; Gennaro E; Zimba I; Liotta G; Buonomo E
    Pediatr Infect Dis J; 2014 Mar; 33(3):295-300. PubMed ID: 23799517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inequalities by educational level in response to combination antiretroviral treatment and survival in HIV-positive men and women in Europe.
    Socio-economic Inequalities and HIV Working Group for Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in Euro-Coord
    AIDS; 2017 Jan; 31(2):253-262. PubMed ID: 27662557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attrition and Mortality of Children Receiving Antiretroviral Treatment through the Universal Coverage Health Program in Thailand.
    Teeraananchai S; Kerr SJ; Puthanakit T; Bunupuradah T; Ruxrungtham K; Chaivooth S; Law MG; Chokephaibulkit K
    J Pediatr; 2017 Sep; 188():210-216.e1. PubMed ID: 28606372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda.
    Mills EJ; Bakanda C; Birungi J; Mwesigwa R; Chan K; Ford N; Hogg RS; Cooper C
    AIDS; 2011 Mar; 25(6):851-5. PubMed ID: 21330903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.